lb1908: a novel car-t cell therapy targeting claudin 18.2 in gi malignancies
Published 1 year ago • 273 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
0:34
expanding indications for a cldn18.2-specific car t-cell therapy in gi cancers
-
2:16
safety and efficacy of a cldn18.2-specific car t-cell therapy in gi adenocarcinoma
-
0:51
claudin 18.2 as an emerging target in gastrointestinal cancers
-
2:17
claudin 18.2 and fgfr2b as novel targets in gastric cancer
-
6:48
car-t cell therapy against caludin 18.2 for gi cancers
-
0:55
future directions for cldn18.2-specific car t-cell therapy in gi cancers
-
2:01
salvage ct041 cldn18.2-specific car t-cell therapy for patients with advanced gi malignancies
-
4:55
dan's story: car t-cell therapy treatment for lymphoma
-
1:07
claudin 18.2: a biomarker for gastric cancer
-
2:27
car-t cell therapy for the treatment of gastric cancer
-
1:04
what does the future hold for car-t cells in gastric cancers?
-
1:33
a look at how car-t cell therapy works
-
2:33
cellular therapy: latest advancements in car t-cell therapy to fight cancer | mass general brigham
-
2:08
targeting cldn18.2 with zolbetuximab in gastric and gej cancer
-
25:08
car t cell therapy- the long sought cure for cancer
-
1:12
ann lacasce, md, on car t-cell therapy
-
1:54
what is car t-cell therapy? | duke health
-
1:33
a look at how car-t cell therapy works
-
3:26
car t-cell therapy | ucla health jonsson comprehensive cancer center